Literature DB >> 15547750

Loss of imprinting of PEG1/MEST in lung cancer cell lines.

Hirofumi Nakanishi1, Tetsuji Suda, Motonobu Katoh, Akiko Watanabe, Tadashi Igishi, Masahiro Kodani, Shingo Matsumoto, Masaki Nakamoto, Yasushi Shigeoka, Tetsuro Okabe, Mitsuo Oshimura, Eiji Shimizu.   

Abstract

Paternally expressed imprinted gene 1/mesoderm-specific transcript (PEG1/MEST) is an imprinted gene expressed from the paternal allele. Recently, frequent loss of imprinting (LOI) of PEG1/MEST has been reported in lung adenocarcinomas. It is suggested that the LOI may be involved in pathogenesis of lung adenocarcinoma. In the present study, incidence of LOI of PEG1/MEST was examined in lung cancer cell lines, including small cell lung cancer (SCLC). Among 50 cell lines tested, 20 cell lines were heterozygous for the AflIII site of the PEG1/MEST gene. In these heterozygotes, biallelic expression was observed in 9 cell lines (45%), monoallelic in 11 (55%). In cell lines of non-small cell lung cancer (NSCLC), 62% (8 of 13) exhibited biallelic expression. In SCLC, only 1 of 7 cell lines (14%) showed biallelic expression. LOI of PEG1/MEST in the NSCLC cell line is significantly frequent compared with that in SCLC cell lines (p=0.043). This result supports the possibility that LOI may be related to tumorigenesis and malignant transformation, especially in NSCLC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15547750

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  Insights into the role of DNA methylation in disease through the use of mouse models.

Authors:  Melissa Conerly; William M Grady
Journal:  Dis Model Mech       Date:  2010 May-Jun       Impact factor: 5.758

2.  Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cells via up-regulation of MEST through NF-κB1.

Authors:  Zhengyi Ruan; Dong Zhao
Journal:  FASEB J       Date:  2019-10-01       Impact factor: 5.191

3.  Variable imprinting of the MEST gene in human preimplantation embryos.

Authors:  John D Huntriss; Karen E Hemmings; Matthew Hinkins; Anthony J Rutherford; Roger G Sturmey; Kay Elder; Helen M Picton
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

4.  Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12.

Authors:  Yusuke Kobayashi; Takatsune Shimizu; Hideaki Naoe; Arisa Ueki; Joe Ishizawa; Tatsuyuki Chiyoda; Nobuyuki Onishi; Eiji Sugihara; Osamu Nagano; Kouji Banno; Shinji Kuninaka; Daisuke Aoki; Hideyuki Saya
Journal:  Am J Pathol       Date:  2011-07-23       Impact factor: 4.307

5.  Gene expression of mesoderm-specific transcript is upregulated as preadipocytes differentiate to adipocytes in vitro.

Authors:  Yoshito Kadota; Masumi Yanagawa; Tomoko Nakaya; Takashige Kawakami; Masao Sato; Shinya Suzuki
Journal:  J Physiol Sci       Date:  2012-07-01       Impact factor: 2.781

6.  MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers.

Authors:  Min Soo Kim; Hyun Sook Lee; Yun Jae Kim; Do Yup Lee; Sung Gyun Kang; Wook Jin
Journal:  Cell Death Differ       Date:  2019-03-22       Impact factor: 15.828

Review 7.  Molecular Markers with Predictive and Prognostic Relevance in Lung Cancer.

Authors:  Alphy Rose-James; Sreelekha Tt
Journal:  Lung Cancer Int       Date:  2012-09-19

8.  MethPat: a tool for the analysis and visualisation of complex methylation patterns obtained by massively parallel sequencing.

Authors:  Nicholas C Wong; Bernard J Pope; Ida L Candiloro; Darren Korbie; Matt Trau; Stephen Q Wong; Thomas Mikeska; Xinmin Zhang; Mark Pitman; Stefanie Eggers; Stephen R Doyle; Alexander Dobrovic
Journal:  BMC Bioinformatics       Date:  2016-02-24       Impact factor: 3.169

9.  Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.

Authors:  Magdalena Bryś; Monika Migdalska-Sęk; Dorota Pastuszak-Lewandoska; Ewa Forma; Karolina Czarnecka; Daria Domańska; Ewa Nawrot; Jacek Wilkosz; Waldemar Różański; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2013-01-04       Impact factor: 3.064

10.  Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study.

Authors:  Karolina H Czarnecka; Monika Migdalska-Sęk; Adam Antczak; Dorota Pastuszak-Lewandoska; Jacek Kordiak; Ewa Nawrot; Daria Domańska; Dorota Kaleta; Paweł Górski; Ewa Barbara Brzeziańska
Journal:  Mol Biol Rep       Date:  2013-10-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.